ISTANBUL, November 4, 2016 /PRNewswire/ --
Shortly after commencing production, Abdi İbrahim Global Pharm, Turkish pharmaceutical leader Abdi İbrahim's Kazakhstan subsidiary, qualified for GMP certification, one of the key systems in good manufacturing practices. "As regards our foreign investments, not only do we expand geographically but also we strive to maximize our production capacity. We are proud to be granted GMP certification with our $60-million Kazakhstan plant in such a short time after commencing operations," commented Nezih Barut, Abdi İbrahim Chairman, on the facilities.
Offering pioneering, bold and innovative services for healing the life and the future for 105 years, Abdi İbrahim approaches its 2020 goals with its Kazakhstan investment, the most critical foreign investment.
Abdi İbrahim invested 285 million dollars in its Esenyurt campus, which features a production facility as well as R&D and logistics centers. After breaking ground on Turkey's largest biotechnological pharmaceutical manufacturing facility with a total investment budget of $100 million last year, Abdi İbrahim began production at its $60-million Kazakhstan plant, which boasts an annual capacity of 24 million units.
Only a short time after groundbreaking in 2013, Abdi İbrahim's Kazakhstan facilities qualified for GMP certification, a benchmark in best manufacturing practices. Abdi İbrahim Global Pharm, operating across a 12,000 square meter indoor area and employing 190 people, will produce approximately 100 products, predominantly diabetes care and anti-viral products, as well as products for treatment of central nervous system and cardiovascular diseases.
On the investment in Kazakhstan, Abdi İbrahim Chairman Nezih Barut noted: "Our plant in Kazakhstan is an indicator of our determination to become a powerful actor in global markets, one of the five growth areas within our 2020 strategy. As of now, we employ a total of around 190 people in Kazakhstan, and 95 personnel in the plant. First exports from the Kazakhstan plant went to Afghanistan and Azerbaijan. In 2017, Georgia will join those countries as well. We aim to expand our current potential by exporting to the Eurasian Customs Union and CIS member countries in the upcoming years. As we near 2020, we will maintain our momentum in the free market by stepping up exports. Our goal for Kazakhstan is $40 million."
Esra Erdinc +90(212)-366-84-00, firstname.lastname@example.org
SOURCE Abdi Ibrahim